Pyridoxine and pyridoxal analogues: new uses

Details Pyridoxine and pyridoxal analogues: new uses Pyridoxine and pyridoxal analogues: new uses

2005-05-24

2005-05-24

Davis, Zinna Northington (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S340000, C514S341000, C514S345000, C514S346000, C546S272400, C546S268400, C546S274100, C546S291000, C546S300000

Reexamination Certificate

active

06897228

ABSTRACT:
The invention provides pyridoxal and pyridoxine analogues, pharmaceutical compositions containing pyridoxine and pyridoxal analogues, and methods of administering pharmaceutical compositions containing a therapeutically effective amount of at least one of these analogues. In accordance with the present invention, the pyridoxal and pyridoxine analogues can be used in the treatment or prevention of of heparin induced thrombocytopenia (HIT, stroke, and ischemia, and in the treatment of symptoms thereof. The the pyridoxal and pyridoxine analogues can be used in neuroprotection.

REFERENCES:
patent: 3206463 (1965-09-01), Baetz
patent: 3910921 (1975-10-01), Esanu
patent: 3987177 (1976-10-01), Giudicelli et al.
patent: 4032534 (1977-06-01), Chodkiewicz
patent: 4036844 (1977-07-01), Thorne et al.
patent: 4053607 (1977-10-01), Thorne et al.
patent: 4137316 (1979-01-01), Esanu
patent: 4167562 (1979-09-01), Evers
patent: 4361570 (1982-11-01), Fici
patent: 4369172 (1983-01-01), Schor et al.
patent: 4374841 (1983-02-01), Descamps et al.
patent: 4515771 (1985-05-01), Fine
patent: 4567179 (1986-01-01), Lombardino
patent: 4569938 (1986-02-01), Esanu
patent: 4569939 (1986-02-01), Esanu
patent: 4581363 (1986-04-01), Esanu
patent: 4605741 (1986-08-01), Zagnoli et al.
patent: 4696920 (1987-09-01), Bentzen et al.
patent: 4730042 (1988-03-01), Hege et al.
patent: 4735950 (1988-04-01), Esanu
patent: 4735956 (1988-04-01), Baldwin et al.
patent: 4837239 (1989-06-01), Benjamin et al.
patent: 4843071 (1989-06-01), Hohenwarter
patent: 4962121 (1990-10-01), Hamberger et al.
patent: 5001115 (1991-03-01), Sloan
patent: 5053396 (1991-10-01), Blass
patent: 5118505 (1992-06-01), Koltringer
patent: 5130324 (1992-07-01), Ulrich et al.
patent: 5132115 (1992-07-01), Wolter et al.
patent: 5210083 (1993-05-01), Pfirrmann
patent: 5213813 (1993-05-01), Kornecki et al.
patent: 5254557 (1993-10-01), Buckle et al.
patent: 5254572 (1993-10-01), Serfontein
patent: 5272165 (1993-12-01), Ulrich et al.
patent: 5278154 (1994-01-01), Lacoste et al.
patent: 5288716 (1994-02-01), Speck
patent: 5326757 (1994-07-01), Demopoulos
patent: 5328453 (1994-07-01), Sibalis
patent: 5372999 (1994-12-01), Schneider et al.
patent: 5385937 (1995-01-01), Stamler et al.
patent: 5420112 (1995-05-01), Lewis et al.
patent: 5441972 (1995-08-01), Ogata et al.
patent: 5504090 (1996-04-01), Neely
patent: 5563126 (1996-10-01), Allen et al.
patent: 5569459 (1996-10-01), Shlyankevich
patent: 5569648 (1996-10-01), Lewis et al.
patent: 5631271 (1997-05-01), Serfontein
patent: 5633228 (1997-05-01), Lewis et al.
patent: 5648335 (1997-07-01), Lewis et al.
patent: 5728684 (1998-03-01), Cheng et al.
patent: 5733884 (1998-03-01), Barbul et al.
patent: 5733916 (1998-03-01), Neely
patent: 5770215 (1998-06-01), Moshyedi
patent: 5795873 (1998-08-01), Allen
patent: 5804163 (1998-09-01), Gibby et al.
patent: 5804594 (1998-09-01), Murad
patent: 5833998 (1998-11-01), Biedermann et al.
patent: 5834446 (1998-11-01), Dow et al.
patent: 5840685 (1998-11-01), Fujii et al.
patent: 5847008 (1998-12-01), Doebber et al.
patent: 5858017 (1999-01-01), Demopulos et al.
patent: 5859051 (1999-01-01), Adams et al.
patent: 5874420 (1999-02-01), Pelleg
patent: 5874443 (1999-02-01), Kiely et al.
patent: 5888514 (1999-03-01), Weisman
patent: 5944020 (1999-08-01), Markov et al.
patent: 6043259 (2000-03-01), Dhalla et al.
patent: 6417204 (2002-07-01), Haque
patent: 6548519 (2003-04-01), Haque
patent: 831350 (1976-01-01), None
patent: 863754 (1978-05-01), None
patent: 561 183 (1975-04-01), None
patent: 1 958 226 (1970-05-01), None
patent: 24 61 742 (1976-07-01), None
patent: 37 05 549 (1988-09-01), None
patent: 43 44 751 (1995-06-01), None
patent: 0 121 036 (1984-10-01), None
patent: 0 144 051 (1985-06-01), None
patent: 0 270 026 (1988-06-01), None
patent: 0 416 248 (1991-03-01), None
patent: 0 891 719 (1999-01-01), None
patent: 846376 (1941-03-01), None
patent: 1323941 (1963-12-01), None
patent: 5552 (1967-12-01), None
patent: 5801 (1968-03-01), None
patent: 6453 (1968-12-01), None
patent: 1579544 (1969-08-01), None
patent: 2 034 539 (1970-12-01), None
patent: 2101010 (1972-03-01), None
patent: 2255883 (1975-07-01), None
patent: 2428640 (1980-01-01), None
patent: 1 013 939 (1965-12-01), None
patent: 1172800 (1969-12-01), None
patent: 1 201 014 (1970-08-01), None
patent: 1 297 080 (1972-11-01), None
patent: 1 360 536 (1974-07-01), None
patent: 1 493 993 (1977-12-01), None
patent: 1 597 428 (1981-09-01), None
patent: 2 254 556 (1992-10-01), None
patent: 48-21959 (1973-07-01), None
patent: 54-17130 (1979-02-01), None
patent: 10-158244 (1998-06-01), None
patent: 2000-26295 (2000-01-01), None
patent: WO 8300085 (1983-01-01), None
patent: WO 9119500 (1991-12-01), None
patent: WO 9418965 (1994-09-01), None
patent: WO 9828310 (1998-07-01), None
patent: WO 9903365 (1999-01-01), None
patent: WO 9953928 (1999-10-01), None
Medicure brochure, “Pyridoxine as a Template for the Design of Novel Anti-Platelet Agents,” 1 page (Date Unknown).
Patrono, C., “Aspirin: New Cardiovascular Uses for an Old Drug,”The American Journal of Medicine,vol. 110, pp. 62S-65S (Jan. 8, 2001).
Sexton, R. Jr., Abstract, 1 page, “Aspirin in cardiovascular disease,”Tenn. Med.,vol. 94, No. 6, pp. 208-210, (Jun. 2001).
Arbuzov, S., “Pharmacological Properties of the Products of the Condensation of Phenamine with Some Metabolites”,Farmakol. Toksikol,vol. 31, No. 3, pp. 373-376 (1968) (Abstract only).
Arbuzov, S., “Synthesis and Pharmacological Investigation of Some New Compounds Related Structurally to Some Natural Metabolites”,Conf. Hung. Ther. Invest. Pharmacol., Soc. Pharmacol. Hung., 4th Meeting,pp. 489-502 (1966) (Abstract only).
Aybak, M. et al., “Effect of Oral Pyridoxine Hydrochloride Supplementation on Arterial Blood Pressure in Patients with Essential Hypertension”,Drug Res.,vol. 45, No. 12, pp. 1271-1273 (1995).
“B Vitamins May Cut Heart Disease Risk”,Heirarchical Health Letter,1 page (1998).
Baliga, B. et al., “Hyperhomocysteinemia in Type 2 Diabetes Mellitus: Cardiovascular Risk Factors and Effect of Treatment with Folic Acid and Pyridoxine”,Endocrine Practice,vol. 6, No. 6, pp. 435-441 (Nov./Dec. 2000).
Barrett, S., “Homocysteine: A Cardiovascular Risk Factor Worth Considering”, http://www.quackwatch.com/03HealthPromotion/homocysteine.html, 2 pages (©1997).
Bennett, R. et al., “Vitamin B6Phosphonic Acids”,Journal of Medicinal and Pharmaceutical Chemistry,vol. 1, No. 3, pp. 213-221 (1959).
Bernstein, A., “Vitamin B6in Clinical Neurology”,Annals of New York Academy of Sciences,vol. 585, pp. 250-260 (1990).
Berger, A.R. et al., “Dose response, coasting, and differential fiber vulnerability in human toxic neuropathy: A prospective study of pyridoxine neurotoxicity”,Neurology,vol. 42, No. 7, pp. 1367-1370 (Jul. 1992).
Bhagavan, H. et al., “Effect of Postweanling Pyridoxine Deficiency on Growth and Concentration of the Coenzyme Pyridoxal-5′-phosphate in Heart, Kidneys, Lungs, and Adrenals in Rats”,Pediatr. Res.,vol. 10, pp. 730-732 (1976).
Bode, W. et al., “Pyridoxal-5′-Phosphate and Pyridoxal Biokinetics in Male Wistar Rats Fed Graded Levels of Vitamin B-6”,J. Nutr.,vol. 121, No. 11, pp. 1738-1745 (Nov. 1991).
Chasan-Taber, L. et al.,“A Prospective Study of Folate and Vitamin B6and Risk of Myocardial Infarction in US Physicians”,Journal of the American College of Nutrition,vol. 15, No. 2, pp. 136-143 (Apr. 1996).
Cho, Y. et al., “In Vitro Evidence for a Vitamin B-6 Requirement in Carnitine Synthesis”,J. Nutr.,vol. 120, pp. 258-265 (1990).
“Computer Generated Search Reports”, 70 pages (May 1999).
Ebadi, M. et al., “Convulsant Activity of Pyridoxal Sulphate and Phosphononethyl Pyridoxal: Antagonism by GABA and its Synthetic Analogues”,Neuropharmacology,vol. 22, No. 7, pp. 865-873 (1983).
Ellis, J. et al., “Prevention of Myocardial Infarction by Vitamin B6&

Affiliated with

Also associated with

Rating

Pyridoxine and pyridoxal analogues: new uses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyridoxine and pyridoxal analogues: new uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridoxine and pyridoxal analogues: new uses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3412462